Submission of Annual Report for the Financial Year 2025-26 Pursuant to Regulation 34 and other relevant provisions of the SEBI (Listing Obligations & Disclosure Requirements), 2015.

Venmax Drugs and Pharmaceuticals Ltd submitted its Annual Report for the Financial Year 2025-26, including the Notice of 37th Annual General Meeting, to be held on September 26, 2026. The report includes the Standalone Audited Financial Statements, the Report of the Directors, and the Independent Auditor's Report.